Sensulin Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4M
- Investors
-
18
Sensulin General Information
Description
Developer of glucose-responsive insulin designed for treating diabetes. The company's insulin helps to eliminate the need for separate basal and prandial insulin and reduce the need for glucose monitoring, enabling patients suffering from diabetes to eliminate the need for multiple injections daily.
Contact Information
Website
www.sensulin.comCorporate Office
- 12 East California
- Suite 200
- Oklahoma City, OK 73104
- United States
Corporate Office
- 12 East California
- Suite 200
- Oklahoma City, OK 73104
- United States
Sensulin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 28-Sep-2021 | $4M | Completed | Pre-Clinical Trials | ||
| 6. Later Stage VC (Series B) | 23-May-2018 | Completed | Product Development | |||
| 5. Later Stage VC (Series A) | 13-Jan-2016 | Completed | Product Development | |||
| 4. Grant | 01-Dec-2013 | Completed | Startup | |||
| 3. Seed Round | 28-Feb-2013 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2013 | $500K | $500K | Completed | Startup | |
| 1. Angel (individual) | 25-Apr-2012 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sensulin Comparisons
Industry
Financing
Details
Sensulin Competitors (1)
One of Sensulin’s competitors is Sernova Biotherapeutics, a Corporation company based in Mississauga, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sernova Biotherapeutics | Corporation | Mississauga, Canada |
Sensulin Patents
Sensulin Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2012223210-A1 | Vesicle compositions | Active | 02-Mar-2011 | ||
| AU-2012223210-B2 | Vesicle compositions | Inactive | 02-Mar-2011 | ||
| CA-2822021-A1 | Vesicle compositions | Active | 02-Mar-2011 | ||
| CA-2822021-C | Vesicle compositions | Active | 02-Mar-2011 | ||
| EP-2680822-A1 | Vesicle compositions | Active | 02-Mar-2011 | A61K38/28 |
Sensulin Signals
Sensulin Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Century Venture Partners | Venture Capital | Minority | ||
| Cortado Ventures | Venture Capital | Minority | ||
| StartUp Health | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| AngelMD | Angel Group | Minority |
Sensulin FAQs
-
When was Sensulin founded?
Sensulin was founded in 2011.
-
Where is Sensulin headquartered?
Sensulin is headquartered in Oklahoma City, OK.
-
What is the size of Sensulin?
Sensulin has 6 total employees.
-
What industry is Sensulin in?
Sensulin’s primary industry is Drug Discovery.
-
Is Sensulin a private or public company?
Sensulin is a Private company.
-
What is Sensulin’s current revenue?
The current revenue for Sensulin is .
-
How much funding has Sensulin raised over time?
Sensulin has raised $7.83M.
-
Who are Sensulin’s investors?
Century Venture Partners, Cortado Ventures, StartUp Health, , and AngelMD are 5 of 18 investors who have invested in Sensulin.
-
Who are Sensulin’s competitors?
Sernova Biotherapeutics is a competitor of Sensulin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process